BETA-BLOCKING PROPERTIES OF THE CLASS-I ANTI-ARRHYTHMIC DRUG PROPAFENONE IN HEALTHY-HUMAN SUBJECTS

被引：0
|
作者：
MCLEOD, AA
SHAND, DG
机构：
[1] DUKE UNIV,MED CTR,DIV CARDIOL,DURHAM,NC 27710
[2] DUKE UNIV,MED CTR,DIV CLIN PHARMACOL,DURHAM,NC 27710
来源：
CLINICAL RESEARCH | 1983年 / 31卷 / 02期
关键词：
D O I：
暂无
中图分类号：
R-3 [医学研究方法]; R3 [基础医学];
学科分类号：
1001 ;
摘要：
引用
收藏
页码：A251 / A251
页数：1
相关论文
共 23 条
  • [21] KINETICS OF ONSET OF RATE-DEPENDENT EFFECTS OF CLASS-I ANTI-ARRHYTHMIC DRUGS ARE IMPORTANT IN DETERMINING THEIR EFFECTS ON REFRACTORINESS IN GUINEA-PIG VENTRICLE, AND PROVIDE A THEORETICAL BASIS FOR THEIR SUBCLASSIFICATION
    CAMPBELL, TJ
    CARDIOVASCULAR RESEARCH, 1983, 17 (06) : 344 - 352
  • [22] Phase I, First-in-Human, Single and Multiple Ascending Dose- and Food-Effect Studies to Assess the Safety, Tolerability and Pharmacokinetics of a Novel Anti-hepatitis B Virus Drug, Bentysrepinine (Y101), in Healthy Chinese Subjects
    Liu, Xiaoxue
    Xue, Ling
    Zhang, Hua
    Xu, Qingqing
    Zhang, Shichao
    Ma, Sheng
    Ding, Xiaoliang
    Liu, Linsheng
    Dong, Ji
    Qian, Lifang
    Xia, Wen
    Jiang, Kun
    Huang, Chenrong
    Miao, Liyan
    CLINICAL DRUG INVESTIGATION, 2020, 40 (06) : 555 - 566
  • [23] Phase I, First-in-Human, Single and Multiple Ascending Dose- and Food-Effect Studies to Assess the Safety, Tolerability and Pharmacokinetics of a Novel Anti-hepatitis B Virus Drug, Bentysrepinine (Y101), in Healthy Chinese Subjects
    Xiaoxue Liu
    Ling Xue
    Hua Zhang
    Qingqing Xu
    Shichao Zhang
    Sheng Ma
    Xiaoliang Ding
    Linsheng Liu
    Ji Dong
    Lifang Qian
    Wen Xia
    Kun Jiang
    Chenrong Huang
    Liyan Miao
    Clinical Drug Investigation, 2020, 40 : 555 - 566
123